NorthWest Health Prop Real Est Inv Trust (NWH.UN) Price Target Increased to C$12.50 by Analysts at Royal Bank of Canada

Share on StockTwits

NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN) had its price objective hoisted by Royal Bank of Canada from C$12.00 to C$12.50 in a research report sent to investors on Wednesday, BayStreet.CA reports. The firm currently has a sector perform rating on the stock.

NWH.UN has been the topic of several other research reports. CIBC upped their target price on NorthWest Health Prop Real Est Inv Trust from C$11.00 to C$11.75 in a report on Monday, March 11th. National Bank Financial reiterated a sector perform rating and set a C$10.00 target price on shares of NorthWest Health Prop Real Est Inv Trust in a report on Friday, February 15th. Finally, TD Securities reiterated a market perform rating and set a C$12.00 target price on shares of NorthWest Health Prop Real Est Inv Trust in a report on Thursday, March 21st. Five equities research analysts have rated the stock with a hold rating, The stock presently has an average rating of Hold and a consensus target price of C$11.95.

NWH.UN opened at C$11.88 on Wednesday. NorthWest Health Prop Real Est Inv Trust has a 52-week low of C$10.34 and a 52-week high of C$11.70.

About NorthWest Health Prop Real Est Inv Trust

NorthWest Healthcare Properties Real Estate Investment Trust (TSX: NWH.UN) (NorthWest) is an unincorporated, open-ended real estate investment trust established under the laws of the Province of Ontario. As at December 31, 2018 the REIT provides investors with access to a portfolio of high quality international healthcare real estate infrastructure comprised of interests in a diversified portfolio of 156 income-producing properties and 11.2 million square feet of gross leasable area located throughout major markets in Canada, Brazil, Europe, Australia and New Zealand.

Read More: Hedge Funds Explained

Analyst Recommendations for NorthWest Health Prop Real Est Inv Trust (TSE:NWH.UN)

Receive News & Ratings for NorthWest Health Prop Real Est Inv Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NorthWest Health Prop Real Est Inv Trust and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Walmart  Shares Gap Up  After Better-Than-Expected Earnings
Walmart Shares Gap Up After Better-Than-Expected Earnings
Desjardins Brokers Lower Earnings Estimates for TeraGo Inc.
Desjardins Brokers Lower Earnings Estimates for TeraGo Inc.
Financial Analysis: Designer Brands  versus Shoe Carnival
Financial Analysis: Designer Brands versus Shoe Carnival
Imperial Metals  PT Lowered to C$2.75 at TD Securities
Imperial Metals PT Lowered to C$2.75 at TD Securities
NorthWest Health Prop Real Est Inv Trust  Price Target Increased to C$12.50 by Analysts at Royal Bank of Canada
NorthWest Health Prop Real Est Inv Trust Price Target Increased to C$12.50 by Analysts at Royal Bank of Canada
Phillips 66  Expected to Post Quarterly Sales of $28.10 Billion
Phillips 66 Expected to Post Quarterly Sales of $28.10 Billion


© 2006-2019 Ticker Report